Financings in medical technology are on an uptick for May 2011, even if the $107 million raised by the implantable defibrillator company Cameron Health is considered an anomaly. There remains an impressive list of big financings that have come through this month, including $60 million to genome diagnostics company CardioDx, $30 million to neurology therapeutics company Neuronetics, $22 million to fibrin sealant company ProFibrix NV and the $20 million to surgical sealant company Lifebond.
Financings in medical technology are on an uptick for May 2011, even if the $107 million raised by the implantable defibrillator company Cameron Health is considered an anomaly. There remains an impressive list of big financings that have come through this month, including $60 million to genome diagnostics company CardioDx, $30 million to neurology therapeutics company Neuronetics, $22 million to fibrin sealant company ProFibrix NV and the $20 million to surgical sealant company Lifebond.
The complete list of May 2011 financings in medical technologies is detailed at link (be sure to bookmark to capture financings through the end of the month).
